0001127602-22-012868.txt : 20220502
0001127602-22-012868.hdr.sgml : 20220502
20220502172444
ACCESSION NUMBER: 0001127602-22-012868
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220428
FILED AS OF DATE: 20220502
DATE AS OF CHANGE: 20220502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferruzzi Mario
CENTRAL INDEX KEY: 0001659317
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07626
FILM NUMBER: 22883377
MAIL ADDRESS:
STREET 1: 777 E. WISCONSIN AVENUE
CITY: MILWAUKEE
STATE: WI
ZIP: 53202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SENSIENT TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000310142
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 390561070
STATE OF INCORPORATION: WI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 EAST WISCONSIN AVENUE
CITY: MILWAUKEE
STATE: WI
ZIP: 53202-5304
BUSINESS PHONE: 4142716755
MAIL ADDRESS:
STREET 1: 777 EAST WISCONSIN AVENUE
CITY: MILWAUKEE
STATE: WI
ZIP: 53202-5304
FORMER COMPANY:
FORMER CONFORMED NAME: UNIVERSAL FOODS CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-04-28
0000310142
SENSIENT TECHNOLOGIES CORP
SXT
0001659317
Ferruzzi Mario
777 E. WISCONSIN AVENUE
MILWAUKEE
WI
53202
1
Common Stock
2022-04-28
4
A
0
1060
0
A
7589.676
D
Common Stock
2022-04-28
4
F
0
665
84.98
D
6924.676
D
Common Stock
209.576
I
Spouse's ESOP
Deferred Stock
Common Stock
1968.096
1968.096
D
Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated.
Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant.
Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing.
Deferred stock converts to common stock on a one-for-one basis.
Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
/s/ John J. Manning, Attorney-in-Fact for Dr. Ferruzzi
2022-05-02